Which test evaluates rapid, dose-related improvement in muscle strength in myasthenia gravis by acetylcholinesterase inhibition?

Which test evaluates rapid, dose-related improvement in muscle strength in myasthenia gravis by acetylcholinesterase inhibition?

• A. Ice pack test
• B. Edrophonium (Tensilon) test
• C. EMG
• D. CSF analysis

Answer: (B)

In myasthenia gravis, antibodies impair transmission at the neuromuscular junction by reducing functional acetylcholine receptors. Blocking acetylcholine breakdown with a short-acting acetylcholinesterase inhibitor raises acetylcholine levels quickly, enhancing neuromuscular transmission. The Edrophonium (Tensilon) test uses this short-acting inhibitor to elicit a rapid, dose-related improvement in muscle strength within seconds to minutes, with the effect persisting only briefly as the drug wears off. A positive, transient improvement supports the diagnosis of MG and helps confirm that weakness is due to impaired NMJ transmission rather than another cause. Clinically, watch for possible cholinergic side effects like bradycardia or bronchospasm, and have atropine ready as an antidote if needed. Other tests don’t demonstrate this immediate pharmacologic response. The ice pack test can support MG in ptosis but isn’t a direct/pharmacologic test of NMJ transmission. Repetitive nerve stimulation on EMG shows typical decremental responses but does not reproduce a rapid improvement with drug administration. CSF analysis isn’t diagnostic for MG.

In myasthenia gravis, antibodies impair transmission at the neuromuscular junction by reducing functional acetylcholine receptors. Blocking acetylcholine breakdown with a short-acting acetylcholinesterase inhibitor raises acetylcholine levels quickly, enhancing neuromuscular transmission. The Edrophonium (Tensilon) test uses this short-acting inhibitor to elicit a rapid, dose-related improvement in muscle strength within seconds to minutes, with the effect persisting only briefly as the drug wears off. A positive, transient improvement supports the diagnosis of MG and helps confirm that weakness is due to impaired NMJ transmission rather than another cause. Clinically, watch for possible cholinergic side effects like bradycardia or bronchospasm, and have atropine ready as an antidote if needed.

Other tests don’t demonstrate this immediate pharmacologic response. The ice pack test can support MG in ptosis but isn’t a direct/pharmacologic test of NMJ transmission. Repetitive nerve stimulation on EMG shows typical decremental responses but does not reproduce a rapid improvement with drug administration. CSF analysis isn’t diagnostic for MG.